ITP

Takeda reports positive data from Phase IIb trial of ITP treatment
Clinical Trials Arena
Mon, 06/24/24 - 11:18 am
Takeda
mezagitamab
TAK-079
ITP
clinical trials. dengvaxia
Sanofi gears up for approval of its BTK inhibitor, meets Phase III endpoint
Clinical Trials Arena
Tue, 04/23/24 - 10:51 am
Sanofi
rilzabrutinib
Btk inhibitors
ITP
J&J’s next myeloma drug, Argenx’s second act and a new question for Bluebird: 3 ASH takeaways
BioPharma Dive
Mon, 12/12/22 - 10:56 pm
ASH 2022
JNJ
talquetamab
Multiple Myeloma
Argenx
Bluebird Bio
Vyvgart
ITP
ASH: With immune thrombocytopenia win, argenx proves efgartigimod's no one-trick pony in autoimmune disease
Fierce Pharma
Sun, 12/11/22 - 01:32 pm
ASH 2022
ITP
efgartigimod
Argenx
Study links AstraZeneca COVID-19 shot to bleeding disorder ITP
Pharmaforum
Thu, 06/10/21 - 11:00 am
AstraZeneca
vaccines
ITP
COVID-19
Belgium biotech argenx nabs Bayer speedy review voucher for a cool $98M
Fierce Biotech
Mon, 11/23/20 - 10:16 am
Argenx
Bayer
FDA
priority reviews
efgartigimod
ITP
FDA Grants Expanded Use of Promacta for Novartis
Yahoo/24-7 Wall St
Tue, 08/25/15 - 08:30 am
FDA
Novartis
Promacta
chronic immune thrombocytopenia
ITP
Rigel Pharmaceuticals initiates Phase 3 studies of fostamatinib in ITP
Yahoo/Fly on the Wall
Wed, 07/16/14 - 10:42 am
fostamatinib
Rigel Pharmaceuticals
ITP
3SBIO Files for Approval on Three New Drugs
Seeking Alpha
Wed, 01/21/09 - 09:37 am
3SBio
TPIAO
ITP
NuLeusin
renal cell carcinoma
EPIAO